News

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operations Rubix Life ...
The Glaucoma Research Foundation (GRF) announced it has appointed Cynthia Steel, PhD, MBA, as Chief Scientific Officer (CSO).
OpenAI’s underwhelming new GPT-5 model suggests progress is slowing – and competition is changing. Everyone is asking: what ...
Jon Walsh, founder, chief scientific officer, Unlearn, explains how AI and digital twins are helping clinical trials become more efficient, patient-centric, and capable of supporting innovative study ...
Jon Walsh, founder, chief scientific officer, Unlearn, explains how AI and digital twin technologies are being applied to improve data transparency, ensure reproducibility, and strengthen the ...
Michael J. Sofia, the inventor of the Hepatitis C cure, has joined the Pennsylvania Biotechnology Center in Doylestown, ...
Traws Pharma, Inc. ( NASDAQ: TRAW) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Charles Parker - Interim Chief Financial Officer David Pauza - Corporate Participant Iain D. Dukes - ...
Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients ...
Revenue-- Revenue net of returns was $86,000, reflecting intentional reductions in ClearUp marketing and unit sales. Operating expenses-- Operating expenses were $2.0 million, up from $1.3 million in ...
"Michelle brings an exceptional combination of scientific acumen, business strategy, and global biotech experience," said Andrew Busey, Form Bio co-founder and outgoing CEO. "She's the right leader at ...
Life expectancy has risen dramatically since 1900, reshaping how we understand aging. Scientists now view skin not just as a ...